Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pelvic and Para-aortic Lymphadenectomy in Patients With Stage I or II Endometrial Cancer With High Risk of Recurrence

NCT03438474 is registered in ClinicalTrials.gov with Philipps University Marburg as lead sponsor.

NCT NCT03438474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03438474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pelvic and Para-aortic Lymphadenectomy in Patients With Stage I or II Endometrial Cancer With High Risk of Recurrence
Lead sponsor
Philipps University Marburg
Phase
Not applicable
Overall status
Recruiting
Start date
March 28, 2018
Completion date
February 15, 2029
Enrollment
640 (estimated)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of endometrium stage i, cancer of endometrium stage ii